Le Lézard
Classified in: Health, Science and technology
Subject: PDT

LexisNexis Risk Solutions Identity Verification and Authentication Now Available to Health Systems using Epic to Validate Users Accessing the MyChart® Patient Portal


ATLANTA, Sept. 21, 2018 /PRNewswire/ -- LexisNexis® Risk Solutions announced today that its identity authentication and verification solutions, InstantID® Q&A and Instant Verify, can now be integrated with the MyChart® patient portal. The integration offers Epic customers an easy-to-implement way to strengthen efforts to protect patient data.

LexisNexis Risk Solutions Health Care. (PRNewsfoto/LexisNexis Risk Solutions)

Identities are validated in real-time, quickly giving the right individuals the right access to information and flagging those requiring additional validation on the spot. A layer of identity proofing solutions delivered through the use of sophisticated LexisNexis linking technology, LexID®, and an extensive consumer referential database make it possible.

"The digitization of healthcare is moving full speed ahead, creating more remote access channels to sensitive patient records," said Josh Schoeller, senior vice president and general manager, Health Care, LexisNexis Risk Solutions. "As a result, healthcare organizations have to find effective ways of balancing patient access and patient data security without being intrusive or slowing down their ability to get the information they need. Our identity verification solutions give users peace of mind that their data is readily available to them but is safeguarded against identity theft."

The MyChart integration includes two important LexisNexis solutions. Each is designed to assess different criteria in the user validation process:

  1. LexisNexis® Instant Verify quickly determines if the identity being entered is an actual person by performing multiple data checks on the user's identity data against extensive public records and proprietary databases.
  2. LexisNexis® InstantID Q&A is a knowledge-based authentication solution that utilizes non-intrusive questions to determine if the person submitting the identity data is the true owner of that identity. LexisNexis also offers the benefit of recognizing suspicious patterns in identity events that are known to be indicative of fraud.

These identity-proofing solutions can be used as standalones or together in a multi-factor authentication decision flow. Epic customers who choose to use these solutions will be taking steps to keep personally identifiable information secure and protect their patients' privacy.

For more information, go to: https://risk.lexisnexis.com/products/instant-verify-for-healthcare  

About LexisNexis Risk Solutions

LexisNexis Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX Group (LSE: REL/NYSE: RELX), a global provider of information and analytics for professional and business customers across industries. RELX is a FTSE 100 company and is based in London. For more information, please visit www.risk.lexisnexis.com, and www.relx.com.

SOURCE LexisNexis Risk Solutions


These press releases may also interest you

at 07:05
At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying...

at 07:00
Bristol Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo® (nivolumab) in combination with cisplatin and gemcitabine for the...

at 07:00
R&D Leader and software architect with more than three decades of experience designing, developing,...

at 07:00
Gordian Biotechnology, an in vivo drug discovery and development...

at 07:00
GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company) a leading provider of technology enabled Revenue Cycle Management (RCM) & Risk Adjustment Solutions for Healthcare Providers and Payers, announced the acquisition of CCD Health, a...

at 07:00
Many American children...



News published on and distributed by: